全文获取类型
收费全文 | 305181篇 |
免费 | 27626篇 |
国内免费 | 12329篇 |
专业分类
耳鼻咽喉 | 2680篇 |
儿科学 | 8576篇 |
妇产科学 | 2957篇 |
基础医学 | 41819篇 |
口腔科学 | 6226篇 |
临床医学 | 32497篇 |
内科学 | 47253篇 |
皮肤病学 | 5283篇 |
神经病学 | 16383篇 |
特种医学 | 9411篇 |
外国民族医学 | 132篇 |
外科学 | 24395篇 |
综合类 | 51697篇 |
现状与发展 | 71篇 |
一般理论 | 1篇 |
预防医学 | 12833篇 |
眼科学 | 5840篇 |
药学 | 27710篇 |
169篇 | |
中国医学 | 15767篇 |
肿瘤学 | 33436篇 |
出版年
2024年 | 490篇 |
2023年 | 4403篇 |
2022年 | 5505篇 |
2021年 | 12176篇 |
2020年 | 10920篇 |
2019年 | 9780篇 |
2018年 | 9662篇 |
2017年 | 10465篇 |
2016年 | 11131篇 |
2015年 | 11883篇 |
2014年 | 18581篇 |
2013年 | 20471篇 |
2012年 | 17557篇 |
2011年 | 19178篇 |
2010年 | 15543篇 |
2009年 | 14493篇 |
2008年 | 15289篇 |
2007年 | 15684篇 |
2006年 | 14324篇 |
2005年 | 13073篇 |
2004年 | 11727篇 |
2003年 | 10360篇 |
2002年 | 8278篇 |
2001年 | 7393篇 |
2000年 | 6152篇 |
1999年 | 5375篇 |
1998年 | 4987篇 |
1997年 | 4753篇 |
1996年 | 4204篇 |
1995年 | 3861篇 |
1994年 | 3486篇 |
1993年 | 2787篇 |
1992年 | 2478篇 |
1991年 | 2234篇 |
1990年 | 1751篇 |
1989年 | 1701篇 |
1988年 | 1608篇 |
1987年 | 1302篇 |
1986年 | 1187篇 |
1985年 | 1638篇 |
1984年 | 1378篇 |
1983年 | 952篇 |
1982年 | 1114篇 |
1981年 | 880篇 |
1980年 | 746篇 |
1979年 | 587篇 |
1978年 | 438篇 |
1977年 | 353篇 |
1976年 | 295篇 |
1975年 | 130篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
71.
72.
目的:探究翁连解毒汤治疗浊毒内蕴型溃疡性结肠炎(Ulcerative Colitis,UC)临床疗效及可能的作用机制。方法:选取2016年2月至2018年12月在攀枝花学院附属医院收治的浊毒内蕴型UC患者130例作为研究对象,按照入院先后顺序分为对照组和观察组,每组65例。对照组常规西医治疗,观察组加用翁连解毒汤,观察2组治疗前、完成治疗后T细胞、NK细胞、炎性反应因子、凝血功能、生命质量变化,完成治疗后总结疗效。结果:观察组患者在NK细胞、T淋巴细胞组成、CR、TNF-α、IL-1 β、ESR、内毒素、IL-10、FIB、PLT、APTT改善方面的效果较对照组更优,组间差异有统计学意义(P<0.05)。观察组患者完成治疗后的生命质量量表各维度评分及总评分改善效果优于对照组患者(P<0.05),且临床总有效率和组织病理学疗效率均高于对照组患者(P<0.05)。结论:翁连解毒汤能抑制浊毒内蕴型UC炎性反应,改善高凝状态,提高机体免疫功能,从而提高疗效和生命质量。 相似文献
73.
74.
75.
76.
77.
D. Baker G. Pryce L. K. James K. Schmierer G. Giovannoni 《European journal of neurology》2020,27(2):221-228
Clinical trials are probably the most informative experiments to help an understanding of multiple sclerosis (MS) biology. Recent successes with CD20‐depleting antibodies have focused attention towards B cell subsets as important mediators in MS. The trial of tabalumab (NTC00882999), which inhibits B cell activation factor (BAFF), is reported and reviewed and this trial is contrasted with the trial on the inhibition of a proliferation‐inducing ligand (APRIL) and BAFF using atacicept (NCT00642902). Both tabalumab and atacicept induce depletion of mature B cells and inhibit antibody formation, but they fail to deplete memory B cells and do not inhibit relapsing MS. Atacicept is reported to augment memory B cell responses and may precipitate relapse, suggesting the importance of APRIL. However, BAFF inhibition can enhance peripheral blood memory B cell responses, which was not associated with augmented relapse. Although other interpretations are possible, these data further support the hypothesis that memory B cells may be of central importance in relapsing MS, as they are the major CD20+ B cell subset expressing APRIL receptors. They also suggest that quantitative and/or qualitative differences in B cell responses or other factors, such as an immune‐regulatory effect associated with APRIL, may be important in determining whether MS reactivates following neutralization of peripheral B cell maturation and survival factors. 相似文献
78.
《Brain stimulation》2022,15(2):337-351
BackgroundAbnormalities in frontoparietal network (FPN) were observed in many neuropsychiatric diseases including substance use disorders. A growing number of studies are using dual-site-tACS with frontoparietal synchronization to engage this network. However, a computational pathway to inform and optimize parameter space for frontoparietal synchronization is still lacking. In this case study, in a group of participants with methamphetamine use disorders, we proposed a computational pathway to extract optimal electrode montage while accounting for stimulation intensity using structural and functional MRI.MethodsSixty methamphetamine users completed an fMRI drug cue-reactivity task. Four main steps were taken to define electrode montage and adjust stimulation intensity using 4x1 high-definition (HD) electrodes for a dual-site-tACS; (1) Frontal seed was defined based on the maximum electric fields (EF) predicted by simulation of HD montage over DLPFC (F3/F4 in EEG 10–10), (2) frontal seed-to-whole brain context-dependent correlation was calculated to determine connected regions to frontal seeds, (3) center of connected cluster in parietal cortex was selected as a location for placing the second set of HD electrodes to shape the informed montage, (4) individualized head models were used to determine optimal stimulation intensity considering underlying brain structure. The informed montage was compared to montages with large electrodes and classic frontoparietal HD montages (F3-P3/F4-P4) in terms of tACS-induced EF and ROI-to-ROI task-based/resting-state connectivity.ResultsCompared to the large electrodes, HD frontoparietal montages allow for a finer control of the spatial peak fields in the main nodes of the FPN at the cost of lower maximum EF (large-pad/HD: max EF[V/m] = 0.37/0.11, number of cortical sub-regions that EF exceeds 50% of the max = 77/13). For defining stimulation targets based on EF patterns, using group-level head models compared to a single standard head model results in comparable but significantly different seed locations (6.43 mm Euclidean distance between the locations of the frontal maximum EF in standard-space). As expected, significant task-based/resting-state connections were only found between frontal-parietal locations in the informed montage. Cue-induced craving score was correlated with frontoparietal connectivity only in the informed montage (r = ?0.24). Stimulation intensity in the informed montage, and not in the classic HD montage, needs 40% reduction in the parietal site to reduce the disparity in EF between stimulation sites.ConclusionThis study provides some empirical insights to montage and dose selection in dual-site-tACS using individual brain structures and functions and proposes a computational pathway to use head models and functional MRI to define (1) optimum electrode montage for targeting FPN in a context of interest (drug-cue-reactivity) and (2) proper transcranial stimulation intensity. 相似文献
79.
《Archives of Cardiovascular Diseases》2022,115(10):505-513
Central illustration: cumulative major adverse cardiac events (MACE) and bioresorbable vascular scaffold (BVS) thrombosis rates after 1, 2, 3, 4 and 5 years. 相似文献
80.
《Journal of endodontics》2020,46(10):1455-1464
IntroductionThe aim of this study was to investigate whether mineral trioxide aggregate (MTA) can be modified with caffeic acid (CA) to form caffeic acid/mineral trioxide aggregate (CAMTA) cement and to evaluate its physicochemical and biological properties as well as its capability in immune suppression and angiogenesis.MethodsMTA was immersed in trishydroxymethyl aminomethane buffer with CA to allow coating onto MTA powders. X-ray diffractometry and tensile stress-strain tests were conducted to assess for physical characteristics of CAMTA and to evaluate for successful modification of MTA. Then, the CAMTA cement was immersed in simulated body fluid to evaluate its hydroxyapatite formation capabilities and Si release profiles. In addition, RAW 264.7 cells and human dental pulp stem cells were used to evaluate CAMTA’s immunosuppressive capabilities and cell responses, respectively. hDPSCs were also used to assess CAMTA’s angiogenic capabilities.ResultsThe X-ray diffractometry results showed that CA can be successfully coated onto MTA without disrupting or losing MTA’s original structural properties, thus allowing us to retain the initial advantages of MTA. CAMTA was shown to have higher mechanical properties compared with MTA and had rougher pitted surfaces, which were hypothesized to lead to enhanced adhesion, proliferation, and secretion of angiogenic- and odontogenic-related proteins. In addition, it was found that CAMTA was able to enhance hydroxyapatite formation and immunosuppressive capabilities compared with MTA.ConclusionsCAMTA cements were found to have improved physicochemical and biological characteristics compared with their counterpart. In addition, CAMTA cements had enhanced odontogenic, angiogenic, and immunosuppressive properties compared with MTA. All of the results of this study proved that CAMTA cements could be a biomaterial for future clinical applications and tissue engineering use. 相似文献